163 related articles for article (PubMed ID: 17448868)
1. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer.
Williams SG; Taylor JM; Liu N; Tra Y; Duchesne GM; Kestin LL; Martinez A; Pratt GR; Sandler H
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):24-33. PubMed ID: 17448868
[TBL] [Abstract][Full Text] [Related]
2. A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?
Tang JI; Williams SG; Tai KH; Dean J; Duchesne GM
Brachytherapy; 2006; 5(4):256-61. PubMed ID: 17118320
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of PSA nadir < or =4 ng/mL within 4 months of high-dose radiotherapy for locally advanced prostate cancer.
Nickers P; Albert A; Waltregny D; Deneufbourg JM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):73-7. PubMed ID: 16503381
[TBL] [Abstract][Full Text] [Related]
4. Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer.
Kupelian PA; Ciezki J; Reddy CA; Klein EA; Mahadevan A
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):16-22. PubMed ID: 17996382
[TBL] [Abstract][Full Text] [Related]
5. Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy.
Suwinski R; Wzietek I; Tarnawski R; Namysl-Kaletka A; Kryj M; Chmielarz A; Wydmanski J
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):793-9. PubMed ID: 17499451
[TBL] [Abstract][Full Text] [Related]
6. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
[TBL] [Abstract][Full Text] [Related]
7. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
King CR; Spiotto MT
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):23-7. PubMed ID: 18207668
[TBL] [Abstract][Full Text] [Related]
8. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison.
Leborgne F; Fowler J
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1441-6. PubMed ID: 19395194
[TBL] [Abstract][Full Text] [Related]
9. Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?
Pos FJ; Hart G; Schneider C; Sminia P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1168-73. PubMed ID: 16376486
[TBL] [Abstract][Full Text] [Related]
10. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.
Zaider M; Zelefsky MJ; Cohen GN; Chui CS; Yorke ED; Ben-Porat L; Happersett L
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):702-13. PubMed ID: 15708248
[TBL] [Abstract][Full Text] [Related]
11. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
Stone NN; Potters L; Davis BJ; Ciezki JP; Zelefsky MJ; Roach M; Shinohara K; Fearn PA; Kattan MW; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):341-6. PubMed ID: 18597953
[TBL] [Abstract][Full Text] [Related]
12. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
[TBL] [Abstract][Full Text] [Related]
14. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
15. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.
Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Shioyama Y; Araya M; Mukumoto N; Mitsumori M; Teshima T;
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):759-65. PubMed ID: 19327908
[TBL] [Abstract][Full Text] [Related]
16. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
Yu HH; Song DY; Tsai YY; Thompson T; Frassica DA; DeWeese TL
Urology; 2007 Jul; 70(1):111-6. PubMed ID: 17656219
[TBL] [Abstract][Full Text] [Related]
17. Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?
Roach M
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():26-8. PubMed ID: 18167004
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer.
Sato M; Mori T; Shirai S; Kishi K; Inagaki T; Hara I
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1002-9. PubMed ID: 18448272
[TBL] [Abstract][Full Text] [Related]
19. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
[TBL] [Abstract][Full Text] [Related]
20. Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer.
Jani AB; Feinstein JM; Pasciak R; Krengel S; Weichselbaum RR
Urology; 2006 May; 67(5):1007-11. PubMed ID: 16635512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
